CA2322619A1 - Milieu et procede de propagation et de multiplication virales - Google Patents
Milieu et procede de propagation et de multiplication virales Download PDFInfo
- Publication number
- CA2322619A1 CA2322619A1 CA 2322619 CA2322619A CA2322619A1 CA 2322619 A1 CA2322619 A1 CA 2322619A1 CA 2322619 CA2322619 CA 2322619 CA 2322619 A CA2322619 A CA 2322619A CA 2322619 A1 CA2322619 A1 CA 2322619A1
- Authority
- CA
- Canada
- Prior art keywords
- medium
- cells
- multiplication
- viruses
- viral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0043—Medium free of human- or animal-derived components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32651—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention a pour objet un milieu de propagation et de multiplication virales sur des cellules en culture, caractérisé en ce qu'il est dépourvu de protéines humaines ou animales et en ce qu'il comprend des protéines ou glycoprotéines extraites de pommes de terre ou de concombre, ayant un potentiel mitogène et dont le poids moléculaire est compris entre 1 000 et 200 000 daltons et/ou des hydrolysats d'extraits végétaux.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR98/03,333 | 1998-03-13 | ||
FR9803333A FR2775983B1 (fr) | 1998-03-13 | 1998-03-13 | Milieu et procede de propagation et de multiplication virales |
PCT/FR1999/000578 WO1999047648A2 (fr) | 1998-03-13 | 1999-03-15 | Milieu et procede de propagation et de multiplication virales |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2322619A1 true CA2322619A1 (fr) | 1999-09-23 |
Family
ID=9524203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2322619 Abandoned CA2322619A1 (fr) | 1998-03-13 | 1999-03-15 | Milieu et procede de propagation et de multiplication virales |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1062324A2 (fr) |
JP (1) | JP2002506636A (fr) |
KR (1) | KR20010072556A (fr) |
CN (1) | CN1301297A (fr) |
AU (1) | AU752577B2 (fr) |
BR (1) | BR9908744A (fr) |
CA (1) | CA2322619A1 (fr) |
EA (1) | EA200000934A1 (fr) |
FR (1) | FR2775983B1 (fr) |
HU (1) | HUP0101081A3 (fr) |
IL (1) | IL138250A0 (fr) |
NZ (1) | NZ506872A (fr) |
PL (1) | PL343557A1 (fr) |
SK (1) | SK12882000A3 (fr) |
TR (1) | TR200002641T2 (fr) |
WO (1) | WO1999047648A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9163211B2 (en) | 2002-07-09 | 2015-10-20 | Baxter International Inc. | Animal protein free media for cultivation of cells |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000083657A (ja) * | 1998-07-13 | 2000-03-28 | Chemo Sero Therapeut Res Inst | 日本脳炎ウイルスワクチン |
AT409379B (de) | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
ES2328466T3 (es) * | 2001-03-27 | 2009-11-13 | Vertex Pharmaceuticals Incorporated | Composiciones y metodos utiles para la infeccion por hcv. |
GB0304799D0 (en) | 2003-03-03 | 2003-04-09 | Glaxosmithkline Biolog Sa | Novel method |
US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
EP2522717B1 (fr) | 2006-01-04 | 2014-04-02 | Baxter International Inc | Milieux de culture cellulaire sans oligopeptides |
JP5458536B2 (ja) * | 2008-09-17 | 2014-04-02 | 不二製油株式会社 | 乳酸の製造方法及び乳酸発酵用添加剤 |
CN107043739A (zh) * | 2017-04-24 | 2017-08-15 | 浙江美保龙生物技术有限公司 | 一种Vero细胞培养液添加剂及其制备方法、使用方法 |
CN107129963A (zh) * | 2017-04-24 | 2017-09-05 | 浙江美保龙生物技术有限公司 | 一种df‑1细胞培养液添加剂及其制备方法、使用方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5498537A (en) * | 1994-03-09 | 1996-03-12 | Cellco, Inc. | Serum-free production of packaged viral vector |
FR2732347A1 (fr) * | 1995-03-30 | 1996-10-04 | Bio Media | Extrait vegetal, son procede de preparation et ses applications en medecine humaine ou veterinaire |
CA2258501C (fr) * | 1997-04-16 | 2004-01-20 | Feva N.V. | Extrait vegetal, procede de preparation associe, et utilisations en medecine humaine et veterinaire |
-
1998
- 1998-03-13 FR FR9803333A patent/FR2775983B1/fr not_active Expired - Fee Related
-
1999
- 1999-03-15 SK SK1288-2000A patent/SK12882000A3/sk unknown
- 1999-03-15 EA EA200000934A patent/EA200000934A1/ru unknown
- 1999-03-15 BR BR9908744A patent/BR9908744A/pt not_active IP Right Cessation
- 1999-03-15 JP JP2000536831A patent/JP2002506636A/ja not_active Withdrawn
- 1999-03-15 KR KR1020007010026A patent/KR20010072556A/ko not_active Application Discontinuation
- 1999-03-15 HU HU0101081A patent/HUP0101081A3/hu unknown
- 1999-03-15 AU AU27352/99A patent/AU752577B2/en not_active Ceased
- 1999-03-15 IL IL13825099A patent/IL138250A0/xx unknown
- 1999-03-15 CA CA 2322619 patent/CA2322619A1/fr not_active Abandoned
- 1999-03-15 CN CN99803965A patent/CN1301297A/zh active Pending
- 1999-03-15 NZ NZ506872A patent/NZ506872A/en unknown
- 1999-03-15 TR TR200002641T patent/TR200002641T2/xx unknown
- 1999-03-15 EP EP99907713A patent/EP1062324A2/fr not_active Withdrawn
- 1999-03-15 WO PCT/FR1999/000578 patent/WO1999047648A2/fr not_active Application Discontinuation
- 1999-03-15 PL PL34355799A patent/PL343557A1/xx not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9163211B2 (en) | 2002-07-09 | 2015-10-20 | Baxter International Inc. | Animal protein free media for cultivation of cells |
Also Published As
Publication number | Publication date |
---|---|
JP2002506636A (ja) | 2002-03-05 |
FR2775983A1 (fr) | 1999-09-17 |
BR9908744A (pt) | 2000-12-26 |
TR200002641T2 (tr) | 2000-11-21 |
FR2775983B1 (fr) | 2000-11-10 |
WO1999047648A2 (fr) | 1999-09-23 |
IL138250A0 (en) | 2001-10-31 |
PL343557A1 (en) | 2001-08-27 |
AU752577B2 (en) | 2002-09-26 |
CN1301297A (zh) | 2001-06-27 |
SK12882000A3 (sk) | 2001-05-10 |
HUP0101081A3 (en) | 2003-04-28 |
EP1062324A2 (fr) | 2000-12-27 |
KR20010072556A (ko) | 2001-07-31 |
AU2735299A (en) | 1999-10-11 |
NZ506872A (en) | 2002-03-01 |
HUP0101081A2 (hu) | 2001-07-30 |
EA200000934A1 (ru) | 2001-02-26 |
WO1999047648A3 (fr) | 1999-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6244294B2 (ja) | 細胞を培養するための動物性タンパク質非含有培地 | |
CA2455189C (fr) | Procedes pour realiser un composant actif pour medicament ou agent de diagnostic dans une culture en suspension de cellules mdck | |
KR100797547B1 (ko) | 무혈청 배양 및 부유 배양에서 사용할 수 있는 세포 및상기 세포를 사용하여 백신용 바이러스를 제조하는 방법 | |
AU2002338666B2 (en) | Multiplication of viruses in a cell culture | |
FI121117B (fi) | Menetelmä biologisten tuotteiden tuottamiseksi proteiinittomassa viljelmässä | |
EP0904351B1 (fr) | Cellules animales et procedes de replication des virus de la grippe | |
HU225791B1 (en) | Method for large scale production of virus antigen | |
AU752577B2 (en) | Medium and method for viral propagation and growth | |
KR20110092280A (ko) | pH에 안정한 외피보유 바이러스의 생산 방법 | |
KR20210082119A (ko) | 베로 세포 배양용 저혈청 배지 조성물 및 이의 이용 | |
MXPA00008511A (es) | Medio y metodo para la propagacion y multiplicacion viral | |
CZ20003327A3 (cs) | Prostředí pro propagaci a multiplikaci virů a způsob propagace a multiplikace virů |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |